Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial.
Not yet recruiting
- Conditions
- Warts
- Registration Number
- NCT06973473
- Lead Sponsor
- Assiut University
- Brief Summary
To assess the clinical efficacy and safety of topical imiquimod 5% cream combined with cryotherapy versus either of theme alone for the treatment of common warts by clinical and dermoscopic assessments.
- Detailed Description
Topical Imiquimod 5% cream Combined with Cryotherapy Versus either of them alone in Treatment of Common Warts: A prospective Randomized Comparative Trial
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Patients with common warts diagnosed clinically and by dermoscopy.
- Patients older than 18years old.
Exclusion Criteria
- Pregnancy and lactation.
- Immunosuppression or being under any kind of treatment causing
- absolute or relative immunosuppression.
- Patients with chronic systemic diseases.
- All cases of bleeding tendency or using anticoagulants.
- Concurrent use of systemic or topical treatments of warts in the last 4 weeks.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete clearance rate of common warts. 12 weeks Assessment of complete warts clearance rate at 12weeks to evaluate the efficacy of combination therapy ( imiquimod5%cream+cryotherapy ) compared to topical imiquimod5%cream alone or cryotherapy alone in patients with common wart.
- Secondary Outcome Measures
Name Time Method